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OBJECTIVES: To evaluate the preliminary results obtained using diffusion-weighted magnetic resonance
imaging and the apparent diffusion coefficient for planning computed tomography-guided biopsies of
selected mediastinal lesions.
METHODS: Eight patients with mediastinal lesions suspicious for malignancy were referred for computed
tomography-guided biopsy. Diffusion-weighted magnetic resonance imaging and apparent diffusion
coefficient measurement were performed to assist in biopsy planning with diffusion/computed tomography
fused images. We selected mediastinal lesions that could provide discordant diagnoses depending on the
biopsy site, including large heterogeneous masses, lesions associated with lung atelectasis or consolidation,
lesions involving large mediastinal vessels and lesions for which the results of biopsy using other methods and
histopathological examination were divergent from the clinical and radiological suspicion.
RESULTS: In all cases, the biopsy needle was successfully directed to areas of higher signal intensity on diffusion-
weighted sequences and the lowest apparent diffusion coefficient within the lesion (mean, 0.8 [range, 0.6–
1.1]610-3 mm2/s), suggesting high cellularity. All biopsies provided adequate material for specific histopatho-
logical diagnoses of four lymphomas, two sarcomas and two thymomas.
CONCLUSION: Functional imaging tools, such as diffusion-weighted imaging and the apparent diffusion
coefficient, are promising for implementation in noninvasive and imaging-guided procedures. However,
additional studies are needed to confirm that mediastinal biopsy can be improved with these techniques.
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& INTRODUCTION
Imaging evaluation of mediastinal tumors is essential for
accurately assessing their location, extent and anatomical
relationships with adjacent structures. However, imaging
findings alone cannot be used to accurately determine the
etiology of mediastinal lesions and specific diagnosis is
critical for proper treatment planning and prognosis.
Excellent diagnostic accuracy and a low complication rate
have established computed tomography (CT)-guided per-
cutaneous needle biopsy as an efficient and safe tool for the
specific diagnosis of thoracic lesions (1).
Because needle biopsy supplies only small tumor frag-
ments, selection of the appropriate location within the lesion
is necessary to provide adequate material that represents the
actual behavior of the tumor for analysis (2). This process
can be difficult, especially for large heterogeneous lesions or
those with cystic or necrotic areas. Functional and metabolic
methods have been used to identify regions within the
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lesion that truly represent its aggressiveness for therapeutic
purposes. Contrast-enhanced CT and positron emission
tomography (PET)/CT with 18-fluorodeoxyglucose are
examples of modalities that are routinely used for this
purpose (3–5).
The value of magnetic resonance (MR) imaging in
mediastinal tumor evaluation, especially in the assessment
of vascular and chest wall invasion, has long been considered
to be well established (6). However, recent MR advances,
such as diffusion-weighted (DW) imaging and the apparent
diffusion coefficient (ADC), have made this method useful
for staging, therapeutic planning and response evaluation,
thereby improving approaches for the diagnosis and treat-
ment of patients with mediastinal lesions (7–10). DW
techniques are related to the diffusion of water inside a voxel
(tridimensional pixel) that is contained within the cell
membrane boundaries and greater cellularity thus results in
greater diffusion restriction in tumors and other tissues. The
DW approach was apparently created initially for examina-
tion of the central nervous system (11,12); in this context, it
has been used not only for the detection of acute ischemia but
also for the characterization and differentiation of brain
tumors and intracranial infections, such as abscesses. DW
imaging is based on the random Brownian motion of water
molecules and the extent of tissue cellularity and intactness of
the cell membrane help to determine the extent to which
water molecule diffusion is impeded, which can be assessed
quantitatively using the ADC.
Advanced oncological treatment is based on targeted
therapy, molecular profiling and translational research and
DW MR imaging with the ADC can provide functional
information about tissue cellularity and the integrity of
cellular membranes. Investigators have recently demon-
strated the diagnostic potential of DW MR images and ADC
in oncology (13–16) and several studies have shown that
these sequences are useful in the differential diagnosis of
benign and malignant lesions, including mediastinal lesions
(17,18). Thus, MR imaging can also assist in determining the
most appropriate site for biopsy within a mediastinal lesion.
This application is very important in patients with cancer,
especially those with severe disease, as the avoidance of
inappropriate material collection leading to the need for a
new biopsy is extremely desirable in these patients.
Thus, the purpose of our study was to evaluate the utility
of DW MR imaging and the ADC in planning transthoracic
CT-guided biopsies of mediastinal lesions suspicious for
malignancy.
& PATIENTS AND METHODS
In this prospective study, eight patients with mediastinal
lesions that were suspicious for malignancy based on clinical
and imaging findings and who were referred for initial
transthoracic CT-guided biopsy at our institution between
February 2011 and September 2012 were evaluated. All of
these patients required further evaluation by MR imaging, as
determined by the following criteria: 1) the presence of
multiple or large heterogeneous masses, 2) the association of
lesions with lung atelectasis or consolidation in the adjacent
lung parenchyma, 3) invasion of the chest wall or mediastinal
structures, 4) large vessel involvement and/or 5) biopsy
results obtained via another method that diverged from
the clinical and radiological suspicion. None of the patients
had previously undergone CT-guided biopsy that yielded
inconclusive results. Screening coagulation tests were
ordered routinely and all patients underwent chest MR
imaging 1 h prior to biopsy to assist in procedure planning.
The institutional review board of AC Camargo Cancer Center
approved this study and all patients provided written
informed consent. This investigation was conducted accord-
ing to the principles expressed in the Declaration of Helsinki.
MR imaging was performed with the patients in the
supine position using a 1.5-T unit (Signa HDxt; General
Electric Medical Systems, Milwaukee, WI, USA) with a body
phased-array coil. Before DW imaging, axial T1-weighted
and T2-weighted fast spin-echo images (repetition time/
echo time: 6.3/2.7 ms and 3200/40 ms, respectively) with
fat signal suppression, 6-mm slice thickness, a 30-cm field of
view and a 256 acquisition matrix were obtained.
The DW imaging was performed using a multislice,
single-shot, spin-echo and echo-planar imaging sequence in
the transverse plane. DW images were acquired with no
gated sequence on the basis of prior T1- and T2-weighted
images; this sequence was performed only in the sections in
which the pulmonary lesion was located during breath
holding. Pairs of motion-probing gradients were applied
before and after the 180˚ radiofrequency pulse of the spin-
echo T2-weighted sequence in three orthogonal directions
(X, Y and Z). The DW images were obtained at diffusion
factor (b) values of 0 and 600 s/mm2.
ADC maps were automatically reconstructed for all DW
images and ADCs were measured after defining regions of
interest. Regions within the lesions with the lowest ADC
values were identified for CT-guided biopsy.
Post-contrast T1-weighted imaging was performed using
the same (pre-contrast) parameters and gadopentetate
dimeglumine (Magnevist; Berlex Laboratories, Wayne, NJ,
USA) paramagnetic contrast. A 20-ml dose was adminis-
tered at a rate of 2 ml/s using a power injector.
For each patient, panoramic acquisition of a scout image
was performed with 5–10-mm cuts for biopsy planning
purposes. Then, the DW and CT images were fused using
AquariusNET software (TeraRecon, Foster City, CA, USA)
to obtain the corresponding plans. All image fusion
procedures were very accurate, with millimetric adjust-
ments made by overlapping of images in the same plane
and in the same cut, considering at least three points of
common anatomical reference. An approach enabling CT-
guided direction of the needle tip to the region of greatest
cellularity, as identified by MR imaging performed 1 h prior
to the procedure, was chosen.
All biopsies were performed with a helical CT unit
(HiSpeed; General Electric Medical Systems) using the
cutting needle biopsy technique and an automated 20-
gauge coaxial system (Angiotech, Vancouver, Canada). The
needles used were either 10 cm or 15 cm in length,
depending on the distance between the skin and the lesion.
Local anesthesia was administered routinely and sedation
was not necessary in any case. At least five specimens were
collected from the single needle location chosen under DW
image and ADC guidance in each lesion. The biopsy
specimens were subjected to histological evaluation for
specific diagnosis.
& RESULTS
Five patients in the study sample were male and three
were female; the mean age was 44 (range, 19–63) years.
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Table 1 summarizes the patients’ demographic character-
istics and the radiological and histological characteristics of
the lesions.
All mediastinal biopsies provided adequate material,
enabling specific diagnoses: four cases of lymphoma (one
classical Hodgkin, one gray zone and two classical non-
Hodgkin lymphomas), two cases of sarcoma (one pleo-
morphic and one high-grade peripheral nerve sheath
sarcoma) and two cases of thymoma (one B1 thymoma
and one B3 thymoma). No major complications were
reported after the procedure.
All the biopsied areas showed higher signal intensity on
DW sequences and correspondingly lower ADCs (mean, 0.8
[range, 0.6–1.1]610-3 mm2/s) compared with other areas
within the lesion, suggesting high cellularity (Figures 1 and
2).
& DISCUSSION
Contemporary oncological treatment is based on targeted
therapy and molecular profiling. Within this context, the
ability of the interventional radiologist to obtain tissue
specimens that represent tumor aggressiveness has become
increasingly important (19). Indeed, inadequate biopsies can
cause misdiagnosis and delay appropriate treatment.
Functional imaging methods are essential for effective
image-guided percutaneous biopsy and obviate the need
for more invasive procedures for proper diagnosis and
therapeutic planning (20,21).
The aim of MR image planning is to avoid re-biopsy and
the risks of invasive diagnostic procedures, such as video-
assisted thoracoscopic and open surgical biopsies. The great
advantage of imaging-guided procedures is that they
improves diagnostic yield and are associated with a low
morbidity. Our initial results demonstrated that DW
imaging and the ADC are helpful in determining the most
appropriate biopsy site, thus improving pre-procedural
planning for transthoracic mediastinal biopsy with no major
complications.
DW imaging is a noninvasive modality that can be used to
differentiate malignancies from benign mediastinal tumors;
it also provides useful information for the grading of
mediastinal malignancies (12,13). Images obtained by DW
sequences differ from those acquired by traditional MR
imaging. DW imaging essentially depends on the random
movement (Brownian motion) of water protons through
biological tissue (19), which causes phasic dispersion of the
spins, resulting in signal loss in the diffusion-sensitive
sequence. This sequence enables qualitative analysis of the
diffusion of water molecules through tissues via the
interpretation of the signal strength in the studied region.
Quantitative analysis is possible through ADC calculation
and the assignment of absolute values describing the signal
intensity in the studied region (20). These qualitative and
quantitative analyses are mainly influenced by the presence
of barriers that restrict the diffusion of water molecules in
their microenvironment, producing different contrast levels
in different tissues. The movement of water molecules in the
intracellular, extracellular and intravascular spaces ulti-
mately reflects the barrier integrity in these structures. The
best known example of a diffusion barrier to water
molecules is the cell membrane; other examples of barriers
include cell structural components and cellular and tissue
connections, such as the cytoskeleton, macromolecules,
organelles and tight junctions. Consequently, different
tissues display unique signal intensity levels and ADCs
depending on their particular structures (19,20). A malig-
nancy typically has a high cell density and reduced
extracellular space, both of which decrease the diffusion of
water and result in a higher DW signal intensity and a lower
ADC value. In the present study, areas of hyperintensity on
DW images with lower ADC values were distinct from
other areas within all the lesions.
MR imaging has several advantages over other imaging
techniques for biopsy planning. First, MR imaging provides
unparalleled soft-tissue contrast and exquisite anatomical
detail, enabling the identification of target lesions that
cannot be viewed on ultrasound or CT and the detailed
visualization of the anatomy surrounding the target. This
level of detail aids in preventing collateral damage to
delicate structures that are not typically visible on images
produced using other modalities. Additionally, MR imaging
provides the unique ability to elucidate different tissue
characteristics during a procedure through the use of
different pulse sequences, ranging from simple T1 or T2
weighting to more advanced functions such as flow,
perfusion and diffusion (18,22,23).
Hoffmann et al. (23) reported on the accuracy, duration
and factors influencing MR-guided liver or soft-tissue
biopsy. The major disadvantages of this procedure are the
cost and time requirement. Despite these limitations, MR
imaging should be considered and its use may be justified in
complex cases, including large, heterogeneous and mixed-
pattern lesions, because the failure to collect adequate material
and the resulting need for repeat biopsy increase the risks and
costs of the procedure. MR imaging can also be used to avoid
the risks of ionizing radiation in health professionals and
patients undergoing percutaneous procedures (24). Moreover,
Table 1 - Characteristics of patients with mediastinal lesions who underwent transthoracic biopsy based on magnetic
resonance imaging findings.
Age
(years) Gender
Mediastinal
location Indication Size (mm)
ADC
(610-3 mm2/s) Histopathological diagnosis
22 Male Anterior L, H, CI, MI, VI 170 1.1 Classical Hodgkin lymphoma, nodular sclerosis
62 Female Right posterior L, H 98 0.89 Pleomorphic leiomyosarcoma
63 Male Anterior L, H, MI, VI 90 0.77 B3 thymoma
35 Male Superior L, H, MI, VI 150 0.61 Gray zone lymphoma
32 Male Superior L, H, MI, VI 83 0.65 High-grade peripheral nerve sheath sarcoma
19 Female Anterior L, H, CI, MI, VI 120 0.72 Non-Hodgkin lymphoma
58 Male Anterior L, H, CI, MI 78 0.81 B1 thymoma
61 Female Anterior L, H, CI, MI, VI 92 0.91 Non-Hodgkin lymphoma
ADC: apparent diffusion coefficient; L: large; H: heterogeneous; CI: chest infiltration; MI: mediastinal infiltration; VI: vascular involvement.
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Figure 1 - A 62-year-old woman who presented with a heterogeneous mass in the right posterior mediastinum. The entire mass showed
heterogeneous signal hyperintensity on T2-weighted magnetic resonance images (a) and fused T1- and diffusion-weighted images. (b)
Note the remarkable signal hyperintensity in the posterior periphery of the lesion (arrow) compared with other areas, with definitive
signs of restriction on the apparent diffusion coefficient (ADC) map. (c) The ADC value in the target area was 0.89610-3 mm2/s. The
needle was directed to this area during computed tomography–guided biopsy. (d) Histopathological analysis yielded a diagnosis of
pleomorphic leiomyosarcoma.
Figure 2 - A 35-year-old man with a large mass in the anterior mediastinum. The mass showed heterogeneous signal intensity on T2-
weighted images (a) and fused T1- and diffusion-weighted images. (b) Note the circumscribed areas of signal hyperintensity suggestive
of cysts but also the remarkable signal hyperintensity (arrow) away from the cystic areas near the right anterior lesion margin, with
definitive signs of restriction on the apparent diffusion coefficient (ADC) map. (c) The ADC value in the target area was 0.61610-3 mm2/
s. This mass was subjected to computed tomography–guided biopsy (d), and histopathological examination yielded a diagnosis of gray
zone lymphoma.
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given the high success rate of cancer treatment in children,
these patients are followed for a long time using imaging
methods that expose them to ionizing radiation, increasing
the risk of neoplastic development (25). Thus, MR imaging is
an alternative method that can be used to follow these
patients, reducing the risk of second primary tumor devel-
opment induced by exposure to radiation from diagnostic
methods. MR imaging can also be advantageous in the
evaluation of patients with adverse reactions to intravenous
contrast or impaired renal function (26).
MR/CT image fusion can be performed readily using
commercially available software designed for this purpose
(3–5). This methodology has been used with promising
results for lesions identified by PET/CT (3,4). Tatli et al. (3)
recently described the use of specialized software to fuse
previously acquired PET/CT images with CT images
acquired at the time of biopsy.
Some limitations of this study should be considered. The
small number of cases and the lack of a control arm
prevented us from definitively concluding that MR imaging
made a significant difference in our patients’ biopsies and
no patient underwent control MR examination post-biopsy.
Additionally, a wide and distinct range of ADC values was
identified among the patients, impairing the establishment
of an ADC cutoff value; thus, each lesion was evaluated
separately. However, to our knowledge, this preliminary
study is the first to demonstrate the feasibility of using DW
MR imaging and the ADC for mediastinal procedure
planning. Additional studies, including those comparing
the results of MR- and CT-guided biopsies, are necessary to
further evaluate the impact of this technique on the
diagnostic yield of transthoracic mediastinal biopsy, parti-
cularly in patients with large lesions and/or severe illnesses.
In conclusion, MR imaging has several advantages in
clinical and oncological practice. Functional imaging tools,
such as DW imaging and the ADC, are promising for
implementation in noninvasive and imaging-guided proce-
dures. However, additional studies are needed to confirm
whether mediastinal biopsy can be improved with these
techniques.
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